Demographics, prevalence, and clinical features of the schizo-obsessive subtype of schizophrenia

CNS Spectrums

Volumn 4, Issue 12, 1999, Pages 50-56

  Dominguez, Roberte A ^a   Backman, Karl E ^a   Lugo, Susana C ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLOMIPRAMINE; FLUOXETINE; FLUVOXAMINE; NEUROLEPTIC AGENT; SEROTONIN UPTAKE INHIBITOR;

ADULT; ARTICLE; DEMOGRAPHY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH; OBSESSION; PREVALENCE; PRIORITY JOURNAL; PSYCHOSIS; SCHIZOIDISM; SCHIZOPHRENIA; SCREENING;

EID: 0033437150     PISSN: 10928529     EISSN: None     Source Type: Journal    
DOI: 10.1017/S1092852900006829     Document Type: Article

References (32)

1. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: American Psychiatric Association; 1994.
2. Goodman WK, Price LH, Rassmussen SA, et al. The Yale-Brown Obsessive-Compulsive Scale. Arch Gen Psychiatry. 1989;46:1001-1006.
3. Porto L, Bernianzohn PC, Pollack S, et al. A profile of obsessive-compulsive symptoms in schizophrenia. CNS Spectrums. 1997;2:21-25.
4. Yaryura-Tobias JA, Stevens KP, Neziroglu F, et al. Obsessive-compulsive disorder and schizophrenia: a phenomenological perspective of shared pathology. CNS Speclrums. 1997;2:21-25.
5. Zohar J. Is there room for a new diagnostic subtype - the schizo-obsessive subtype? Ci\S Spectrums. 1997;2:49-50.
6. Fenton WS, McGlashan TH. The prognostic significance of obsessive-compulsive symptoms in schizophrenia. Am J Psychiatry. 1986;143:437-441.
7. Cassaro G, Fini S, Saetton M, et al. Occurrence and clinical correlates of psychiatric comorbidity in patients with psychotic disorders. J Clin Psychiatry. 1998;59:60-68.
8. Zohar J, Sasson Y, Chopra M, et al. Schizo-obsessive subtype: obsessions and delusions. CA'S Spectrums. 1998;3:38-39.
9. Blanc R, Newman S, Orn H. Schizophrenia: lifetime comorbidity in a community sample. Ada Psychiatr Scand. 1987;75:383-391. f
10. Yaryura-Tobias JA, Neziroglu MA, Bergman L. Clomipramine for obsessive-compulsive neurosis: an organic approach. Curr Ther Res Clin £rp. 1976;20:S11-518.
11. Zohar J, Kaplan Z, Benjamin J. Clomipramine treatment of obsessive compulsive symptomatology in schizophrenic patients. J Clin Psychiatry. 1993;54:385-388.
12. Berman I, Sapers BL, Chang HH, et al. Treatment of obsessive-compulsive symptoms in schizophrenic patients with clomipramine. J Clin Psychopharmacol. 1995;15:206-210.
13. Kay SR, Fizbein A., Opler, LA. The positive and negative symptom scale (PAN'SS) for Schizophrenia. Schizophr Bull. 1987;13;261-276.
14. Pulman J, Yassa R, Anath J. Clomipramine treatment of repetitive behavior. Can J Psychiatry. 1984;29:2Si-255.
15. Bark N, Lindenmayer JP. Ineffectiveness of clomipramine for obsessive compulsive symptoms in a patient with schizophrenia. Am J Psychiatry. 1992;149:136-137.
16. Sasson Y, Bernianzohn PC, Zohar J. Treatment of obsessive-compulsive syndromes in schizophrenia. CNS Spectrums. 1997;2:34-45.
17. Dominguez RA. Treatment of obsessive-compulsive disorder in adults. In: Rush AJ, ed. Mood and Anxiety Disorders. Philadelphia, Pa: Williams & Wilkins; 1998:250-272.
18. Tejera CA, Mayerhoff DJ, Safferman AZ, et al. Fluoxetine for obsessional symptoms in schizophrenia. Am J Psychiatry. 199 f;151:149-150.
19. Cassady SL, Thaker GK. Addition of fluoxetine to clozapine. Am J Psychiatry. 1992;149:1274.
20. Reznik I, Sirota P. Combined fluvoxamine and neuroleptic therapy for schizophrenic patients with obsessive compulsive disorder. Isr J Psychiatry Relal Sci. 1996;33:269-270.
21. Baker RW. Fluoxeline and schizophrenia in a patient with obsessional thinking. J Neuropsychiatry Clin Neurosci. 1992;4:232-233.
22. Baker RW, Bermanzohn PC, Wirshing DA, et al. Obsessions, compulsions, clozapine, and risperidone. CJYS Spectrums. 1997;2:26-36.
23. Dodt JE, Byerly MJ, Cuadros C, et al. Treatment of risperidone-induced obsessive-compulsive symptoms with sertraline. Am J Psychiatry. 1997;154:582.
24. Kopala A, Horner HG. Risperidone, serotonergic mechanisms, and obsessive-compulsive symptoms in schizophrenia. Am J Psychiatry. 1994;151:1714-1715.
25. Baker RW, Chengappa KNR, Baird JW, et al. Emergence of obsessive-compulsive symptoms during treatment with clozapine. J Clin Psychiatry. 1992;53:439-442.
26. Ravizza L, Barzega G, Bellino S, et al. Therapeutic effect and safety of adjunctive risperidone in refractory obsessive-compulsive disorder. Psychopharmacol Bull. 1996;32:677-682.
27. Ghaemi SN, Zarate ÇA, Popli AP, et al. Is there a relationship between clozapine and obsessive-compulsive disorder? A retrospective chart review. Compr Psychiatry. 1995;36:267-270.
28. Baker RW, Ames D, Umbricht DS, et al. Obsessive-compulsive symptoms in schizophrenia: a comparison of olanzepine and placebo. Psychopharmacol Bull. 1996;32:89-93.
29. Dominguez RA, Jacobson AF, de la Gandara J, et al. Drug response assessed by the Modified Maudsley Obsessive Compulsive Inventory. Psychopharmacol Bull. 1989;2:215-218.
30. Jacobsen FM. Risperidone in the treatment of affective illness and obsessive-compulsive disorder. J Clin Psychiatry. 1995;56:423-429.
31. Berigan TR, Harazin JS. Response to risperidone addition in fluvoxamine-refractory obsessive-compulsive disorder three cases. J Clin Psychiatry. 1996;57:594-595.
32. Jenike MA. Epidemiology and clinical features of obsessive-compulsive disorder. In: Jenike MA, Baer L, Minichiello WE, eds. Obsessive Compulsive Disorders: Theory and Management. Littleton, Mass: PSG Publishing Co; 1986:23-44.